首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Micro-metastases in stages I and II colon cancer are a predictor of the development of distant metastases and worse disease-free survival.
【24h】

Micro-metastases in stages I and II colon cancer are a predictor of the development of distant metastases and worse disease-free survival.

机译:I和II期结肠癌的微转移是远处转移发生和无病生存期恶化的预测指标。

获取原文
获取原文并翻译 | 示例
           

摘要

Approximately 30% of the patients with Dukes A/B colon carcinoma will develop loco-regional recurrence or distant metastases. The aim of this study was to evaluate if patients with micro-metastases are at higher risk for developing distant metastases and therefore a worse disease-free survival and overall survival. In the period January 2000-January 2002, 137 patients underwent curative surgery for colon cancer. When patients had a Dukes A/B colon carcinoma, additional staining and sectioning on the harvested lymph nodes were performed retrospectively. Lymph nodes were examined using 4 multilevel sections at 250-microm intervals and stained with Pan-Cytokeratin. There were 11 patients with a Dukes A and 61 patients with a Dukes B colon carcinoma. Twenty-two patients developed metastases in time (group I) whereas 50 patients did not (group II). After additional staining and sectioning 41% of the patients of group I and 16% of the patients of group II showed micro-metastases (p<0.05). The 5-year overall survival rate in the group with micro-metastases was 62% against 79% in the group without micro-metastases. The disease-free survival (DFS) was 51% and 72% (p<0.05), respectively. Patients with micro-metastases develop significant more distant metastases in time and have a significant worse DFS.
机译:大约30%的Dukes A / B结肠癌患者会发生局部复发或远处转移。这项研究的目的是评估患有微转移的患者是否有较高的风险发生远处转移,从而使无病生存率和总生存率降低。在2000年1月至2002年1月期间,有137例患者接受了结肠癌的根治性手术。当患者患有Dukes A / B结肠癌时,回顾性地对收获的淋巴结进行额外的染色和切片。使用4个多层切片以250微米的间隔检查淋巴结,并用泛细胞角蛋白染色。有11例Dukes A患者和61例Dukes B结肠癌患者。 22例及时发生转移(I组),而50例未发生转移(II组)。经过额外的染色和切片后,I组41%的患者和II组16%的患者显示了微转移(p <0.05)。有微转移组的5年总生存率为62%,而无微转移组的为79%。无病生存期(DFS)分别为51%和72%(p <0.05)。患有微小转移的患者会随着时间的推移发生明显更远的转移,DFS也明显变差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号